课题基金 / 基金详情

Mechanism of pain generation in the rat model of brachial plexus avulsion and the effect of anti-nerve growth factor receptor (p75 neurotrophin receptor) administration

Mechanism of pain generation in the rat model of brachial plexus avulsion and the effect of anti-nerve growth factor receptor (p75 neurotrophin receptor) administration
臂丛神经撕脱大鼠模型疼痛产生机制及抗神经生长因子受体(p75神经营养素受体)给药的影响
批准号:
23592158
负责人:
KUNIYOSHI Kazuki
金额:
$2.33万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2011
资助国家:
日本
项目状态:
已结题
起止时间:
2011 至 2013

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
In the rat model of brachial plexus avulsion (BPA), pain-related behavior and the extent of glial activation was evaluated. The effect of local and general administration of anti-nerve growth factor receptor (p75 neurotrophin receptor [p75NTR]) antibodies was also evaluated in the BPA model. As a result, rats in the BPA group displayed significant mechanical hyperalgesia in the dermatome innervated by uninjured nerves both ipsilaterally and contra laterally. GFAP-immunoreactive astrocytes and Iba1-immunoreactive microglia were significantly activated on the ipsilateral side in the BPA group. And in the both rats group in which anti-p75NTR was locally or generally, mechanical hyperalgesia was significantly improved. Levels of GFAP-immunoreactive astrocytes and Iba1-immunoreactive microglia in the anti-p75NTR group were significantly reduced.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
TDAG51促进FoxO1核积累调控神经元内质网应激在神经病理性疼痛中的作用及机制研究
  • 批准号:
    JCZRQNB202600612
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
  • 依托单位:
基于菌群时间节律驱动GLU及BMP2/SMAD1诱导多能干细胞探讨太极拳改善老年慢性疼痛机制研究
  • 批准号:
    2026JJ70009
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    张峰
  • 依托单位:
PER1-Nav1.7 调控外周敏化分子网络在颞下颌关节骨关节炎疼痛中的机制探究
  • 批准号:
    JCZRQNB202601057
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
  • 依托单位:
α7nAChR重塑巨噬细胞铁死亡调控脊髓小胶质细胞在神经病理性疼痛中的作用及机制研究
  • 批准号:
    JCZRLH202601116
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
  • 依托单位: